10x Genomics Inc. (TXG)
NASDAQ: TXG
· Real-Time Price · USD
13.24
-0.33 (-2.43%)
At close: Aug 14, 2025, 3:59 PM
13.40
1.21%
After-hours: Aug 14, 2025, 07:30 PM EDT
-2.43% (1D)
Bid | 12.95 |
Market Cap | 1.65B |
Revenue (ttm) | 624.66M |
Net Income (ttm) | -157.04M |
EPS (ttm) | -0.7 |
PE Ratio (ttm) | -18.91 |
Forward PE | -13.09 |
Analyst | Buy |
Ask | 13.4 |
Volume | 5,447,758 |
Avg. Volume (20D) | 3,740,022 |
Open | 13.70 |
Previous Close | 13.57 |
Day's Range | 12.85 - 13.93 |
52-Week Range | 6.78 - 24.76 |
Beta | 2.03 |
Analyst Forecast
According to 0 analyst ratings, the average rating for TXG stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
10x Genomics has released their quartely earnings
on Aug 7, 2025:
Next Earnings Release
10x Genomics Inc. is scheduled to release its earnings on
Oct 28, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-3.98%
TXG stock has given up its prior gain. 10x Genomic...
Unlock content with
Pro Subscription
1 week ago
-3.98%
10x Genomics shares are trading higher after the company reported better-than-expected Q2 financial results and announced it will acquire Scale Biosciences. Also, Barclays raised its price target on the stock from $13 to $15.